What is the Share Price of Cohance Lifesciences Ltd?

Cohance Lifesciences Ltd share price is ₹425.95 As on 17 January, 2026|04:10

Home
>
Stocks
>
Cohance Lifesciences Ltd

Cohance Lifesciences Ltd Share Price

Q: What is the Market Cap of Cohance Lifesciences Ltd?

The Market Cap of Cohance Lifesciences Ltd is ₹18,206 As on 17 January, 2026|04:10

Q: What is PE Ratio of Cohance Lifesciences Ltd?

The P/E ratio of Cohance Lifesciences Ltd is 53 As on 17 January, 2026|04:10

Q: What is PB Ratio of Cohance Lifesciences Ltd?

The PB ratio of Cohance Lifesciences Ltd is 4.30 As on 17 January, 2026|04:10

₹ 425.95 -16.00 (-3.62%)
Updated on 16-01-2026 4:38 PM

Stock Rating

Pros 5

Cons 2

Cohance Lifesciences Ltd Price Performance

Day's Low
₹423

Day's High
₹445.3

₹ 425.95

52-w low
₹423

52-w high
₹1,328

425.95

Day's open
₹445
Previous close
₹441.950012
VWAP
₹430.95
Lower price band
₹353.6
Upper price band
₹530.3

Today's Market Action

The last traded share price of Cohance Lifesciences Ltd was 425.95 down by -3.62% on the NSE. Its last traded stock price on BSE was 425.65 down by -3.58%. The total volume of shares on NSE and BSE combined was 553,299 shares. Its total combined turnover was Rs 23.85 crores.

Cohance Lifesciences Ltd Medium and Long Term Market Action

Cohance Lifesciences Ltd hit a 52-week high of 1,328 on 20-02-2025 and a 52-week low of 423 on 16-01-2026. The stock price of Cohance Lifesciences Ltd is down by -18% over the last one month. It is down by -59.5% over the last one year. Don't forget to check the full stock price history in the table below.

Cohance Lifesciences Ltd Fundamentals

Market Cap (Cr): 18206
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Cohance Lifesciences Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Cohance Lifesciences Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Cohance Lifesciences Ltd

Data not available.

Cohance Lifesciences Ltd FAQ's

What is Share Price of Cohance Lifesciences Ltd?

What is the Market Cap of Cohance Lifesciences Ltd?

What is PE Ratio of Cohance Lifesciences Ltd?

What is PB Ratio of Cohance Lifesciences Ltd?

What is the CAGR of Cohance Lifesciences Ltd?

How to Buy Cohance Lifesciences Ltd Share?

Can I buy Cohance Lifesciences Ltd from Samco?

How do I buy Cohance Lifesciences Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Above Average Sustainable RoE
The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
Great Cash Conversion of Profits
The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 76.50% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
High Pricing Power
The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
Strong Working Capital Cycle
The company has a great working capital cycle of 0 days which results in lower investments in working capital and higher asset turnover. This reduces capital requirement of the business and drives RoE and cash flow generation positively. This is extremely positive for long term shareholders of the business.
High Margin of Safety
The relative margin of safety of investing in the company in current times is relatively higher due to recent correction and consolidation in the stock prices.

Cons

Momentum Strength
The stock is currently exhibiting weak momentum, & is showing weak relative strength.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.34. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(17/01/2026)

121

Margin of Safety Index: Very High

0.00%

0.00% People are bullish about Cohance Lifesciences Ltd

100.00%

100.00 % People are bearish about Cohance Lifesciences Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %